It was demonstrated that when insulin and glutamine are lacking, the lipogenic transcription factor SREBP1 is activated in liver and breast cancer cells, which promotes its trans-activation and increases transcription by binding to glutamine synthetase (GS) promoters (Jhu et al., 2021). Here, SREBF1 is linked to breast cancer.